Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM; Histiocyte Society. Emile JF, et al. Among authors: haroche j. Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10. Blood. 2016. PMID: 26966089 Free PMC article. Review.
[Erdheim-Chester disease].
Haroche J, Amoura Z, Wechsler B, Veyssier-Belot C, Charlotte F, Piette JC. Haroche J, et al. Presse Med. 2007 Nov;36(11 Pt 2):1663-8. doi: 10.1016/j.lpm.2007.04.032. Epub 2007 Jul 6. Presse Med. 2007. PMID: 17618076 Review. French.
CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients.
Arnaud L, Hervier B, Néel A, Hamidou MA, Kahn JE, Wechsler B, Pérez-Pastor G, Blomberg B, Fuzibet JG, Dubourguet F, Marinho A, Magnette C, Noel V, Pavic M, Casper J, Beucher AB, Costedoat-Chalumeau N, Aaron L, Salvatierra J, Graux C, Cacoub P, Delcey V, Dechant C, Bindi P, Herbaut C, Graziani G, Amoura Z, Haroche J. Arnaud L, et al. Among authors: haroche j. Blood. 2011 Mar 10;117(10):2778-82. doi: 10.1182/blood-2010-06-294108. Epub 2011 Jan 14. Blood. 2011. PMID: 21239701 Free article.
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, Emile JF. Haroche J, et al. Blood. 2012 Sep 27;120(13):2700-3. doi: 10.1182/blood-2012-05-430140. Epub 2012 Aug 9. Blood. 2012. PMID: 22879539 Free article.
A 75-year-old woman admitted to the ICU with respiratory failure.
Conrad M, Haroche J, Charlotte F, Hervier B, Amoura Z, Bollaert PE, Gibot S. Conrad M, et al. Among authors: haroche j. Chest. 2012 Oct;142(4):1063-1067. doi: 10.1378/chest.11-2700. Chest. 2012. PMID: 23032457 No abstract available.
BRAF mutations in Erdheim-Chester disease.
Emile JF, Charlotte F, Amoura Z, Haroche J. Emile JF, et al. Among authors: haroche j. J Clin Oncol. 2013 Jan 20;31(3):398. doi: 10.1200/JCO.2012.46.9676. Epub 2012 Dec 17. J Clin Oncol. 2013. PMID: 23248255 No abstract available.
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, Cluzel P, Drier A, Hervier B, Benameur N, Besnard S, Donadieu J, Amoura Z. Haroche J, et al. Blood. 2013 Feb 28;121(9):1495-500. doi: 10.1182/blood-2012-07-446286. Epub 2012 Dec 20. Blood. 2013. PMID: 23258922 Free article.
306 results